Johns Hopkins Hospital Malignant and Benign Brain/CNS

Slides:



Advertisements
Similar presentations
Epidemiology Research at KCI. Epidemiology Epidemiology is the study of the distribution of diseases in the population. Epidemiologic methods are used.
Advertisements

Gayle Greer Clutter, R.T., CTR Program Consultant
States and Cities SOL US II 2c A state is an example of a political region. States may be grouped as part of different regions, depending upon the criteria.
FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.
Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.
Nguyen ML, Sumbry A, Reddy D, Harvey K, Gunthel C, Wang W, Tsui C, Ziemer D, del Rio C, Young JL Increased Incidence of Non AIDS-related Malignancies and.
PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.
 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.
Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.
MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.
PANCREATIC CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY 2009.
THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
1 Sarcoma Ages >= ** Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at.
Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,
GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.
ANALYTIC LUNG CANCER by CLASS N = 351 Class 0: Dx’d at JHH only 1: Dx’d at JHH and received all/part of 1st course tx at JHH 2: Dx’d at an outside facility.
Peterson-Kaiser Health System Tracker What are recent trends in cancer spending and outcomes?
The Burden of Cancer in Connecticut Lou Gonsalves Connecticut Tumor Registry
HEAD/NECK CARCINOMA Johns Hopkins Hospital.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Patterns of Brain and CNS Tumor Incidence and Survival in U.S. Adolescents and Young Adults Ages
Johns Hopkins Hospital Cancer Registry Melanoma
JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator
2c: States grouped by region
NON-SMALL CELL LUNG CANCER
Age and Racial/Ethnic Disparities in the Diagnosis of Breast Cancer in an Urban Population Joanne K. Fagan PhD, Denise Fyffe, PhD, Nadine Jenkins, CTR,
The Five Most Common Cancers:
JOHNS HOPKINS HOSPITAL CANCER REGISTRY
Recent trends in cutaneous melanoma incidence and death rates in the United States,   Ahmedin Jemal, DVM, PhD, Mona Saraiya, MD, MPH, Pragna.
Yueh-Ying Han, PhD, MS. University of Pittsburgh Graduate School of Public Health, Department of Epidemiology in collaboration with University of Pittsburgh.
(2) - Department of Epidemiology and Population Health, and
JOHNS HOPKINS CANCER REGISTRY 2009
ANALYTIC PANCREATIC CANCER by CLASS N = 369
Johns Hopkins Hospital Cancer Registry
Surgical Cancer Treatment
Description of In Situ Tumors Reported to Cancer Registries,
The Five Most Commonly Diagnosed Cancers in Females
Surgical Cancer Treatment
The Five Most Common Cancers:
People living with AIDS in Maine at the end of 1984
Focus on prostate cancer
The 5 Most Commonly Diagnosed Cancers in Males
Ariana Znaor, Joannie Lortet-Tieulent, Ahmedin Jemal, Freddie Bray 
Most Common Causes of Cancer Death in Males
Volume 152, Issue 8, Pages e3 (June 2017)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
The 10 Most Common Cancers: 2012
The 5 Most Commonly Diagnosed Cancers in Males
and total thyroid cancer mortality (USA) from 1993 to 2012
Recent trends in cutaneous melanoma incidence and death rates in the United States,   Ahmedin Jemal, DVM, PhD, Mona Saraiya, MD, MPH, Pragna.
The 10 Most Common Cancers in 2011
department of health and human resources
The 10 Most Common Cancers: 2012
The 10 Most Common Cancers: 2013
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials E Mitry, A Fields,
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
The 10 Most Common Cancers in 2011
Data Analytics course.
NAACCR/IACR Combined Annual Conference 2019
Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study  Jessica A. Davila, Hashem B. El–Serag  Clinical.
The 10 Most Common Cancers: 2013
NAACCR/IACR Annual Conference, June 2019
OncotypeDX DCIS test use and clinical utility: A SEER population-based study Yao Yuan, PhD, MPH, Alison Van Dyke, MD, PhD, Serban Negoita, MD, DrPH & Valentina.
The 20 Most Common Cancers in 2013
Focus on prostate cancer
Presentation transcript:

Johns Hopkins Hospital Malignant and Benign Brain/CNS 2003-2007 February 1, 2009

Brain/CNS (Benign/Malignant Combined) Analytic vs Brain/CNS (Benign/Malignant Combined) Analytic vs. Non-Analytic 2003-2007 n = 2153 * Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.

Brain/CNS (Benign/Malignant Combined) Age at Diagnosis by Gender, All Cases 2003-2007 n = 2153 298 243 227 194 183 163 121 129 96 78 74 70 66 58 67 19 40 27

Brain/CNS (Benign/Malignant Combined) by Race, All Cases 2003-2007 n = 2153 939 865 52 46 120 19 28 84

Brain/CNS Benign vs. Malignant, All Cases 2003-2007 n = 2153

Brain/CNS (Benign/Malignant Combined) by Maryland Counties 2003-2007 n = 1124

Brain/CNS (Benign/Malignant Combined) by State at Diagnosis 2003-2007 n = 2153

Johns Hopkins Hospital Malignant Brain/CNS 2003-2007

Brain/CNS Malignant Analytic vs. Non-Analytic 2003-2007 n = 989 * Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.

Brain vs CNS Malignant by Year 2003-2007 n = 989 * Analytic - Initially Diagnosed and/or received all or part of 1st course treatment at JHH **Non-Analytic - Initially diagnosed & treated elsewhere to JHH for treatment of recurrent, metastatic or progression of disease.

Brain/CNS Malignant Age at Diagnosis by Gender, All Cases 2003-2007 n = 989 124 91 87 94 69 66 61 60 56 43 51 42 39 29 29 26 14 8

Brain/CNS Malignant Race by Gender, All Cases 2003-2007 n = 989 483 354 49 37 14 28 12 12

Brain/CNS Malignant by State at Diagnosis 2003-2007 n = 989

Brain/CNS Malignant by Maryland Counties 2003-2007 n = 549

Brain Malignant* by Treatment, Class 1-2** 2003-2007 n = 728 *Excludes CNS Tumors **class 1 – Diagnosed at JHH and part/all of first course treatment at JHH class 2 – Diagnosed elsewhere and all/part of first course treatment at JHH

CNS Malignant by Treatment, Class 1-2** 2003-2007 n = 91 Died before tx – 11 Refused – 10 Unknown – 6 Xrt recomm unk if done – 3 Contraindicated - 1 **class 1 – Diagnosed at JHH and part/all of first course treatment at JHH class 2 – Diagnosed elsewhere and all/part of first course treatment at JHH

Brain Malignant* by Histology 2003-2007 n = 879 *Excludes CNS Tumors

CNS Malignant* by Histology 2003-2007 n = 110 *Excludes CNS Tumors

Brain Malignant JHH vs. NCDB Observed Survival Rates 1998-2002 The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah. Data are available for cases diagnosed from 1973 and later for these registries with the exception of Seattle-Puget Sound and Atlanta. The Seattle-Puget Sound and Atlanta registries joined the SEER program in 1974 and 1975, respectively.

CNS Malignant JHH vs. NCDB Observed Survival Rates 1998-2002 The SEER 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah. Data are available for cases diagnosed from 1973 and later for these registries with the exception of Seattle-Puget Sound and Atlanta. The Seattle-Puget Sound and Atlanta registries joined the SEER program in 1974 and 1975, respectively.

Johns Hopkins Hospital Benign Brain/CNS Tumors 2003-2007

Brain/CNS Benign Analytic vs. Non-Analytic 2003-2007 n = 1164

Brain/CNS Benign Brain vs. CNS 2003-2007 n = 1164

Brain/CNS Benign Age at Diagnosis by Gender, All Cases 2003-2007 n = 1164 207 167 119 114 100 87 76 67 55 14 31 37 35 7 6 5 18 19

Brain Benign* Age at Diagnosis by Gender, All Cases 2003-2007 n = 91 11 11 9 8 8 6 6 5 5 5 4 4 4 3 1 1 *Excludes CNS Tumors

CNS Benign Age at Diagnosis by Gender, All Cases 2003-2007 n = 1073 199 163 113 113 95 71 78 64 47 35 3 1 8 20 26 14 5 18

Brain/CNS Benign Race by Gender, All Cases 2003-2007 n = 1164 585 382 34 35 5 16 24 83

Brain Benign* Race by Gender, All Cases 2003-2007 n = 91 42 39 4 5 1 *Excludes CNS Tumors

CNS Benign Race by Gender, All Cases 2003-2007 n = 1073 543 343 78 31 16 24 33 5

Brain/CNS Benign by State at Diagnosis 2003-2007 n=1164

Brain/CNS Benign by Maryland Counties 2003-2007 n= 575

Brain/CNS Benign by Treatment, Class 1-2* 2003-2007 n= 1005 *class 1 – Diagnosed at JHH and part/all of first course treatment at JHH class 2 – Diagnosed elsewhere and all/part of first course treatment at JHH

Brain Benign* by Histology, All Cases 2003-2007 n = 91 *Excludes CNS Tumors

CNS Benign by Histology, All Cases 2003-2007 n = 1073